Sakai Yuji, Tsuyuguchi Toshio, Ishihara Takeshi, Yukisawa Seigo, Sugiyama Harutoshi, Miyakawa Kaoru, Kuroda Yasuhisa, Yamaguchi Taketo, Ozawa Shinichi, Yokosuka Osamu
Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
J Gastroenterol Hepatol. 2009 Jul;24(7):1191-7. doi: 10.1111/j.1440-1746.2009.05878.x.
To compare the outcome of endoscopic therapy for postoperative benign bile duct stricture and benign bile duct stricture due to chronic pancreatitis, including long-term prognosis.
The subjects were 20 patients with postoperative benign bile duct stricture and 13 patients with bile duct stricture due to chronic pancreatitis who were 2 years or more after initial therapy. The patients underwent transpapillary drainage with tube exchange every 3 to 6 months until being free from the tube. Successful therapy was defined as a stent-free condition without hepatic disorder.
Endoscopic therapy was successful in 90% (18/20) of the patients with postoperative bile duct stricture. The stent was removed (stent free) in 100% (20/20) of the patients, but jaundice resolved in only 10% (2/20) of patients while biliary enzymes kept increasing. Restructure occurred in 5% (1/20) of the patients, but after repeat treatment the stent could be removed. In patients with bile duct stricture due to chronic pancreatitis the therapy was successful in only 7.7% (1/13) of the patients; the stent was retained in 92.3% (12/13) of the patients during a long period. Severe acute pancreatitis occurred in 3.0% (1/33) of the patients as an accidental symptom attributable to endoscopic retrograde cholangiopancreatography (ERCP); however, it remitted after conservative treatment.
Our results further confirm the usefulness of endoscopic therapy for postoperative benign bile duct strictures and good long-term prognosis of the patients.
比较内镜治疗术后良性胆管狭窄与慢性胰腺炎所致良性胆管狭窄的疗效,包括长期预后。
研究对象为初次治疗后2年或更长时间的20例术后良性胆管狭窄患者和13例慢性胰腺炎所致胆管狭窄患者。患者接受经乳头引流,每3至6个月更换一次引流管,直至无需置管。成功治疗定义为无支架且无肝脏疾病。
内镜治疗对90%(18/20)的术后胆管狭窄患者有效。100%(20/20)的患者取出了支架(无支架),但仅10%(2/20)的患者黄疸消退,而胆汁酶持续升高。5%(1/20)的患者出现再狭窄,但重复治疗后可取出支架。对于慢性胰腺炎所致胆管狭窄患者,治疗仅对7.7%(1/13)的患者有效;92.3%(12/13)的患者长期留置支架。3.0%(1/33)的患者因内镜逆行胰胆管造影(ERCP)出现严重急性胰腺炎这一意外症状;然而,经保守治疗后缓解。
我们的结果进一步证实了内镜治疗对术后良性胆管狭窄的有效性以及患者良好的长期预后。